Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y | 7 | Zacks | ||
Di | OPKO Health Inc reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
Di | Opko Health: EPS verfehlt Schätzungen um 0,02 $ - Umsatz schlechter als erwartet | 3 | Investing.com Deutsch | ||
Di | OPKO HEALTH, INC. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
Di | OPKO Health GAAP EPS of -$0.12 misses by $0.02, revenue of $173.7M misses by $9.29M | 4 | Seeking Alpha | ||
Di | OPKO HEALTH, INC. - 8-K, Current Report | 5 | SEC Filings | ||
Di | OPKO Health, Inc.: OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results | 22 | GlobeNewswire (Europe) | MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights... ► Artikel lesen | |
Sa | OPKO Health Inc expected to post a loss of 9 cents a share - Earnings Preview | 8 | Reuters | ||
03.05. | OPKO Health, Inc.: OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 | 6 | GlobeNewswire (USA) | ||
01.04. | Critical Insights From OPKO Health Analyst Ratings: What You Need To Know | 18 | Benzinga.com | ||
01.04. | OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp | 11 | Zacks | ||
28.03. | Labcorp to buy select assets of OPKO Health's unit; OPKO shares up | 17 | Reuters | ||
28.03. | OPKO HEALTH, INC. - 8-K, Current Report | 6 | SEC Filings | ||
25.03. | OPKO Health (OPK) And Entera Bio Announce Data for GLP-2 | 13 | Zacks | ||
05.03. | OPKO Health, Inc.: AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV | 220 | GlobeNewswire (Europe) | • Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal antibodies... ► Artikel lesen | |
01.03. | OPKO HEALTH, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 6 | SEC Filings | ||
28.02. | OPKO Health's (OPK) Q4 Earnings Match Estimates, Revenues Top | 15 | Zacks | ||
28.02. | OPKO Health Inc reports results for the quarter ended in December - Earnings Summary | 11 | Reuters | ||
27.02. | Opko Health: EPS übertrifft Schätzungen um 0,01 $ - Umsatz besser als erwartet | 14 | Investing.com Deutsch | ||
27.02. | OPKO Health: Q4 Earnings Insights | 2 | Benzinga.com |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.072 |
MERCEDES-BENZ | 2.028 |
PLUG POWER | 1.963 |
BAYER | 1.669 |
TUI | 1.405 |
NEL | 1.389 |
ALLIANZ | 1.345 |
SIEMENS ENERGY | 1.210 |
BYD | 1.044 |
PALANTIR TECHNOLOGIES | 962 |
NVIDIA | 924 |
RWE | 868 |
DEUTSCHE BANK | 854 |
DEUTSCHE LUFTHANSA | 774 |
VOLKSWAGEN | 695 |
RENK GROUP | 679 |
RHEINMETALL | 673 |
NORDEX | 629 |
INFINEON | 619 |
TESLA | 611 |
BASF | 608 |
COMMERZBANK | 602 |
SUPER MICRO COMPUTER | 589 |
AIXTRON SE | 578 |
VARTA | 542 |